1-4 of 4
Ian Lund
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Open Access
Joshua Rivera, Qi Yan, Saeed Daneshmandi, Romain Lannes, Eriko Katsuta, Jee Eun Choi, Prashant K. Singh, Ahmed Belal, Ronald Alberico, Ian Lund, Magan Schaefer, Hamza Hassan, Sarah Parker, Kenneth C. Anderson, Nikhil C. Munshi, Mehmet K. Samur, Philip L. McCarthy, Jens Hillengass, Hemn Mohammadpour
Journal: Blood
Blood blood.2025028963.
https://doi.org/10.1182/blood.2025028963
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of Social Determinants of Health on Survival Outcomes in Multiple Myeloma Patients at a Major Cancer Center

Free
Esraa Abdalla, Malak Alharbi, Sawyer Bawek, Catherine Forbes, Ian Lund, Han Yu, Berthliz Durand, Jens Hillengass, Hamza Hassan, Eugene Przespolewski
Journal: Blood
Blood (2024) 144 (Supplement 1): 5158.
https://doi.org/10.1182/blood-2024-206022
Published: 2024
Journal Articles

Effects of Dose Reductions of Lenalidomide Given As Maintenance Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Free
Ian Lund, Farhan Azad, Kristopher Attwood, Anthony George, Jens Hillengass
Journal: Blood
Blood (2023) 142 (Supplement 1): 3365.
https://doi.org/10.1182/blood-2023-181708
Published: 2023
Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Free
Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5567.
https://doi.org/10.1182/blood-2018-99-112334
Published: 2018